Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

Related Articles by Review for PubMed (Select 15540740)

1.

Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years.

Wirth MP, See WA, McLeod DG, Iversen P, Morris T, Carroll K; Casodex Early Prostate Cancer Trialists' Group.

J Urol. 2004 Nov;172(5 Pt 1):1865-70.

PMID:
15540740
2.

Bicalutamide monotherapy for early stage prostate cancer: an update.

Iversen P.

J Urol. 2003 Dec;170(6 Pt 2):S48-52; discussion S52-4. Review.

PMID:
14610410
3.

Emerging role of adjuvant hormonal therapy.

Mcleod DG.

Urology. 2002 Sep;60(3 Suppl 1):13-20; discussion 21. Review.

PMID:
12231039
4.

Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development.

Kolvenbag GJ, Blackledge GR, Gotting-Smith K.

Prostate. 1998 Jan 1;34(1):61-72. Review.

PMID:
9428389
5.

Bicalutamide: in early-stage prostate cancer.

Carswell CI, Figgitt DP.

Drugs. 2002;62(17):2471-79; discussion 2480-1. Review.

PMID:
12421104
6.

Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer.

Wellington K, Keam SJ.

Drugs. 2006;66(6):837-50. Review. Erratum in: Drugs. 2006;66(15):1987.

PMID:
16706554
7.

An evaluation of bicalutamide in the treatment of prostate cancer.

Schellhammer PF, Davis JW.

Clin Prostate Cancer. 2004 Mar;2(4):213-9. Review.

PMID:
15072604
8.

Adjuvant hormonal treatment - the bicalutamide early prostate cancer program.

Wirth MP, Hakenberg OW, Froehner M.

Front Radiat Ther Oncol. 2008;41:39-48. doi: 10.1159/000139877. Review.

PMID:
18544984
9.
11.

An evaluation of bicalutamide in the treatment of prostate cancer.

Schellhammer PF.

Expert Opin Pharmacother. 2002 Sep;3(9):1313-28. Review.

PMID:
12186624
12.

[Locally advanced prostate cancer: definition, prognosis and treatment].

Plantade A, Massard C, de Crevoisier R, Fizazi K.

Bull Cancer. 2007 Jul;94(7 Suppl):F50-61. Review. French.

PMID:
17845994
13.

[The role of bicalutamide in the treatment of prostate cancer].

Stav SY, Segal G.

Harefuah. 2002 Apr;141(4):379-83, 408, 407. Review. Hebrew.

PMID:
12017896
14.

Antiandrogen monotherapy: indications and results.

Iversen P.

Urology. 2002 Sep;60(3 Suppl 1):64-71. Review.

PMID:
12231053
15.

Treatment of locally advanced prostate cancer--a new role for antiandrogen monotherapy?

Abrahamsson PA.

Eur Urol. 2001;39 Suppl 1:22-8. Review.

PMID:
11114597
16.

Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer.

Kolvenbag GJ, Iversen P, Newling DW.

Urology. 2001 Aug;58(2 Suppl 1):16-23. Review.

PMID:
11502439
17.

Treatment of bicalutamide-induced breast events.

Sieber PR.

Expert Rev Anticancer Ther. 2007 Dec;7(12):1773-9. Review.

PMID:
18062751
18.

The role of antiandrogen monotherapy in the treatment of prostate cancer.

Anderson J.

BJU Int. 2003 Mar;91(5):455-61. Review.

PMID:
12603397
19.

A systematic review of randomized trials in localized prostate cancer.

Alibhai SM, Klotz LH.

Can J Urol. 2004 Feb;11(1):2110-7. Review.

PMID:
15003149
20.

Maximal androgen blockade for advanced prostate cancer.

Klotz L.

Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):331-40. doi: 10.1016/j.beem.2008.01.004. Review.

PMID:
18471790
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk